Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro

European Journal of Cancer

Volumn 35, Issue 2, 1999, Pages 309-315

  Akiyama, M ^a   Horiguchi Yamada, J ^a   Saito, S ^a   Hoshi, Y ^a   Yamada, O ^b   Mizoguchi, H ^b   Yamada, H ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Anticancer agent; Apoptosis; hTERT; Telomerase

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DAUNORUBICIN; ETOPOSIDE; IRINOTECAN; MITOMYCIN C; TELOMERASE;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; DAUDI CELL; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA; LYMPHOMA; NEOPLASM PROTEINS; RNA; RNA, MESSENGER; RNA, NEOPLASM; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0033082415     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00365-7     Document Type: Article

References (31)

1. Blackburn E.H. Structure and function of telomeres. Nature. 266:1991;569-573.
2. Harley C.B., Kim N.W., Prowse K.R., et al. Telomerase, cell immortality, and cancer. Cold Spring Harbor Symp Quant Biol. 59:1994;307-315.
3. Kim N.W., ilatyszek M.A., Prowse K.R., et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
4. Counter C.M., Avilion A.A., LeFeuvre C.E., et al. Telomere shortening associated with chromosome instability in immortal cells which express telomerase activity. EMBO J. 11:1992;1921-1929.
5. Feng J., Funk W.D., Wang S., et al. The RNA component of human telomerase. Science. 269:1995;1236-1241.
6. Nakayama J., Saito M., Nakamura H., Matsuura A., Ishikawa F. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell. 88:1997;875-884.
7. Harrington L., Mcphail T., Mar V., et al. A mammalian telomerase-associated protein. Science. 275:1997;973-977.
8. Broccoli D., Young J.W., De Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA. 92:1995;9082-9086.
9. Holt S.E., Wright W.E., Shay J.W. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol. 16:1996;2932-2939.
10. Hiyama E., Hiyama K., Tatsumoto N., Shay J.W., Yokoyama T. Telomerase activity in human intestine. Int J Oncol. 9:1996;453-458.
11. Taylor R.S., Ramirez R.D., Ogoshi M., Chaffins M., Piatyszek M.A., Shay J.W. Telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol. 106:1996;759-765.
12. Hiyama K., Hirai Y., Kyoizumi S., et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol. 155:1995;3711-3715.
13. Rhyu M.S. Telomeres, telomerase, and immortality. J Natl Cancer Inst. 87:1995;884-894.
14. Autexier C., Greider C.W. Telomerase and cancer: revisiting the telomere hypothesis. TIBS. 21:1996;387-391.
15. Holt S.E., Shay J.W., Wright W.E. Refining the telomere-telomerase hypothesis of aging and cancer. Nature Biotec. 14:1996;836-839.
16. Norton J.C., Piatyszek M.A., Wright W.E., Shay J.W., Corey D.R. Inhibition of human telomerase activity by peptide nucleic acids. Nature Biotec. 14:1996;615-618.
17. Shay J.W., Werbin H., Wright W.E. Telomeres and telomerase in human leukemias. Leukemia. 10:1996;1255-1261.
18. Counter C.M., Gupta J., Harley C.B., Leber B., Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 85:1995;2315-2320.
19. Shimizu S., Eguchi Y., Kamiike W., et al. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene. 12:1996;2045-2050.
20. James C., William G.D., Adi F.G., John D.M., James B.M. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47:1987;936-942.
21. James C., William G.D., Adi F.G., John D.M., James B.M. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res. 47:1987;943-946.
22. Koopman G., Reutelingsperger C.P.M., Kuijten G.A.M., Keehnen R.M.J., Pals S.T., van Oers M.H.J. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
23. Piatyszek M.A., Kim N.W., Weinrich S.L., et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Meth Cell Sci. 17:1995;1-15.
24. Holt S.E., Norton J.C., Wright W.E., Shay J.W. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Meth Cell Sci. 18:1996;237-248.
25. Yamada H., Ochi K., Nakada S., et al. Interferon modulates the messenger RNA of G1-controlling genes to suppress the G1-to-S transition in Daudi cells. Mol Cell Biochem. 152:1995;149-158.
26. Nakamura T.M., Morin G.B., Chapman K.B., et al. Telomerase catalytic subunit homologs from fission yeast and human. Science. 227:1997;955-959.
27. Nakamura J., Tahara H., Tahara E., et al. Telomerase activation by hTRT in human normal fibroblast and hepatocellular carcinomas. Nature Genet. 18:1998;65-68.
28. Ohyashiki J.H., Ohyashiki K., Iwama H., Hayashi S., Toyama K., Shay J.W. Clinical implications of telomerase activity levels in acute leukemia. Clin Cancer Res. 3:1997;619-625.
29. Lee H., Blasco M.A., Gottlieb G.J., Horner II J.W., Greider C.W., DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature. 392:1998;569-574.
30. Faraoni I., Turriziani M., Masci G., et al. Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro. Clin Cancer Res. 3:1997;579-585.
31. Holt S.E., Aisner D.L., Shay J.W., Wright W.E. Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci USA. 94:1997;10687-10692.